Does Aetna Cover ADHD Treatment in West Virginia? A 2026 Guide

Last updated: July 15, 2026

If you have Aetna health insurance in West Virginia and you or a family member is seeking ADHD evaluation or treatment, you may be wondering whether your plan may cover services like therapy, medication management, and telehealth visits. This guide breaks down how Aetna may cover ADHD treatment in West Virginia in 2026, including CVS/Caremark formulary details, the state’s electronic prescribing requirement for controlled substances, prior authorization processes, and how West Virginia’s mental health parity law may protect your access to care.

Ready to find an ADHD provider? Klarity Health connects West Virginia residents with licensed ADHD providers online. Check if you may qualify for ADHD treatment through Klarity →

Does Aetna Cover ADHD Treatment in West Virginia?

Aetna offers commercial health insurance plans in West Virginia, including individual and family plans through the Affordable Care Act (ACA) Marketplace and employer-sponsored group coverage. Most Aetna commercial plans are required to cover mental health and behavioral health services — including ADHD evaluation and treatment — on par with medical and surgical benefits under the Mental Health Parity and Addiction Equity Act (MHPAEA) and West Virginia’s state parity statute, W. Va. Code § 33-25-8r et seq.

Coverage details, cost-sharing amounts, and prior authorization requirements vary by specific plan. Always verify your individual benefits before scheduling care.

What ADHD Services May Be Covered by Aetna in West Virginia?

Most Aetna commercial plans in West Virginia may cover the following ADHD-related services, subject to deductibles, copays, and network requirements:

• Psychiatric evaluation and ADHD diagnostic assessment — initial evaluation by a licensed psychiatrist, nurse practitioner, or physician assistant
• Medication management visits — follow-up appointments to monitor stimulant or non-stimulant ADHD medication effectiveness and tolerability
• Outpatient behavioral therapy — Cognitive Behavioral Therapy (CBT), organizational skills training, and behavioral coaching are commonly covered modalities for ADHD
• Telehealth visits — Aetna typically covers telehealth-delivered ADHD services on the same basis as in-person care for most plan types in West Virginia
• Intensive Outpatient Programs (IOP) — for patients with co-occurring conditions such as anxiety or depression alongside ADHD
• Prescription drug coverage — through CVS/Caremark as the pharmacy benefit manager (PBM) for most Aetna commercial plans

ADHD treatment through telehealth has expanded significantly in West Virginia, particularly for members in rural or underserved counties. Aetna plans that include telehealth parity provisions may cover video-based ADHD evaluations and medication management at the same cost-sharing level as in-office visits.

CVS/Caremark ADHD Medication Formulary (2026)

Aetna uses CVS/Caremark as its pharmacy benefit manager for most commercial plans in West Virginia. The following table reflects typical CVS/Caremark formulary tier placements for common ADHD medications in 2026. Actual tier placement and prior authorization requirements depend on your specific Aetna plan.

Note: Generic lisdexamfetamine (generic Vyvanse) became available in 2023. Its formulary tier and PA requirements vary by Aetna plan — verify with CVS/Caremark or your plan’s drug lookup tool before filling.

Formulary tiers and PA requirements are subject to change. Always verify your specific plan’s formulary at aetna.com or by calling CVS/Caremark directly at 1-800-552-8159.

Electronic Prescribing of Controlled Substances (EPCS) in West Virginia

West Virginia has one of the most comprehensive electronic prescribing of controlled substances (EPCS) laws in the country. Under W. Va. Code § 60A-4-403a, all controlled substance prescriptions in West Virginia — including Schedule II, III, IV, and V — must be transmitted electronically. This applies to all ADHD stimulant medications, which are classified as Schedule II controlled substances.

What this means for Aetna members seeking ADHD treatment in West Virginia:

• Your prescribing provider — whether a psychiatrist, psychiatric nurse practitioner, or physician assistant — must be registered and enabled for EPCS in West Virginia
• Paper or handwritten prescriptions for stimulant ADHD medications are not accepted under West Virginia law
• Telehealth providers prescribing stimulants to West Virginia patients must also comply with EPCS requirements
• Klarity Health providers operating in West Virginia are EPCS-compliant

Schedule II stimulants include: amphetamine salts (Adderall), methylphenidate (Ritalin, Concerta), amphetamine salts ER (Adderall XR), and lisdexamfetamine (Vyvanse). Non-stimulant ADHD medications such as atomoxetine (Strattera generic), guanfacine ER (Intuniv generic), clonidine ER (Kapvay generic), and viloxazine (Qelbree) are not controlled substances — EPCS does not apply to these medications.

Prior Authorization for ADHD Medications Under Aetna in West Virginia

Some Aetna CVS/Caremark formulary tiers require prior authorization (PA) before a stimulant or non-stimulant ADHD medication will be covered. Brand-name stimulants (Vyvanse brand, Adderall brand, Concerta brand) and newer non-stimulants like Qelbree typically require PA, while most generic stimulants and generic non-stimulants do not.

West Virginia SB 267 — Electronic PA Submission Requirement

West Virginia Senate Bill 267 (2024) requires that prior authorization requests for prescription drugs be submitted electronically through designated PA portals. For Aetna plans, PA requests should be submitted through Availity (availity.com) — Aetna’s primary electronic prior authorization portal in West Virginia. Paper PA forms are no longer accepted.

Typical PA review timelines for Aetna ADHD medication requests in West Virginia:

• Standard PA review: 2–3 business days
• Urgent/expedited PA: 24–72 hours
• PA denial appeal (first-level): 30–60 days
• Expedited appeal: 72 hours when clinical urgency is documented

If your ADHD medication PA is denied, Aetna members in West Virginia have the right to appeal. You may also request an Independent Medical Review (IMR) through the West Virginia Insurance Commissioner’s office if internal appeals are exhausted.

West Virginia Mental Health Parity Law and ADHD Coverage

West Virginia’s mental health parity statute, W. Va. Code § 33-25-8r et seq., requires that fully insured health plans in West Virginia cover mental health and behavioral health conditions — including ADHD — at parity with medical and surgical benefits. This means Aetna may not impose more restrictive visit limits, higher cost-sharing, or more burdensome prior authorization requirements for ADHD treatment than it does for comparable medical conditions.

Key parity protections that may benefit Aetna members seeking ADHD care in West Virginia include:

• No separate annual visit limits for ADHD outpatient therapy that are more restrictive than medical outpatient visit limits
• Telehealth for ADHD services must be covered on the same basis as other telehealth services under parity principles
• Prior authorization criteria for ADHD medication must not be more stringent than PA criteria for comparable medical conditions
• Non-quantitative treatment limitations (NQTLs) — such as network adequacy requirements and step therapy protocols — must be applied comparably

ERISA Self-Funded Plan Carve-Out

West Virginia’s state parity statute applies to fully insured commercial plans regulated by the state. However, self-funded employer health plans — including those offered by large manufacturers, chemical companies, natural gas and energy firms, government contractors, and other employers in West Virginia — are regulated under federal ERISA and are not subject to the state statute. These plans are governed directly by the federal MHPAEA. If you are enrolled in a self-funded employer plan, you may request written non-quantitative treatment limitation (NQTL) comparative criteria disclosure from your plan administrator.

Aetna Plan Types in West Virginia

Aetna offers several plan types in West Virginia that may include ADHD coverage. The specific cost-sharing, network, and authorization requirements differ by plan type:

• Aetna Choice POS II — a point-of-service plan with in-network and out-of-network coverage options; ADHD providers accessed in-network typically have lower cost-sharing
• Aetna Select — a managed care plan with a defined provider network; referrals may be required for specialist ADHD evaluations depending on plan design
• Aetna Open Choice PPO — a preferred provider organization plan; members may see out-of-network providers at higher cost-sharing without a referral
• ACA Marketplace plans — Aetna individual and family plans sold through the federal Health Insurance Marketplace (healthcare.gov) in West Virginia; ADHD is covered as an essential health benefit under all metal tier plans

Always confirm whether your specific ADHD provider is in-network before scheduling. Aetna’s provider directory is available at aetna.com or by calling member services at 1-800-872-3862.

How to Verify Your Aetna ADHD Benefits in West Virginia

Before beginning ADHD treatment, these steps may help you understand your coverage and avoid unexpected costs:

1. Call Aetna member services at 1-800-872-3862. Ask specifically: Does my plan cover ADHD evaluation and medication management? Is prior authorization required for my specific medication? What is my out-of-pocket cost for mental health outpatient visits?
2. Check the CVS/Caremark drug formulary by calling 1-800-552-8159 or using the drug lookup tool on caremark.com. Search for your specific ADHD medication by name (generic or brand) and confirm its tier and any PA requirements.
3. Confirm network status for any ADHD provider you are considering by searching Aetna’s provider directory at aetna.com.
4. Request NQTL comparison criteria if you believe your ADHD treatment has been subject to more restrictive limitations than comparable medical care. This is your right under MHPAEA for both fully insured and self-funded plans.
5. Contact the West Virginia Insurance Commissioner at 1-888-879-9842 if you believe Aetna has violated state parity protections or improperly denied an ADHD-related claim.

Get ADHD Treatment Through Klarity Health

Klarity Health connects West Virginia residents with licensed ADHD providers through a fully online telehealth platform. With a network of 2,000+ licensed providers — including psychiatrists, nurse practitioners, and physician assistants — Klarity offers ADHD evaluations, diagnosis, and medication management without requiring an in-person office visit.

Klarity providers are EPCS-compliant for West Virginia, meaning they can legally transmit Schedule II stimulant prescriptions electronically in accordance with W. Va. Code § 60A-4-403a.

Check if you may qualify for ADHD treatment through Klarity Health →

Frequently Asked Questions

Does Aetna cover ADHD evaluations in West Virginia?

Most Aetna commercial plans in West Virginia may cover ADHD diagnostic evaluations performed by a licensed psychiatrist, nurse practitioner, or other qualified mental health provider. Coverage is subject to your plan’s deductible, copay, and network requirements. Verify your specific benefits before scheduling by calling Aetna member services at 1-800-872-3862.

Does Aetna cover Vyvanse or Adderall in West Virginia?

Aetna typically covers generic stimulant ADHD medications through CVS/Caremark at Tier 1–2 (lower cost-sharing). Brand-name medications like Vyvanse brand may require prior authorization and are usually placed at Tier 3–4. Generic lisdexamfetamine (generic Vyvanse) is available and typically at Tier 2–3, though PA requirements vary by plan — verify with CVS/Caremark at 1-800-552-8159 before filling.

Do Aetna ADHD prescriptions require electronic prescribing in West Virginia?

Yes. Under W. Va. Code § 60A-4-403a, all controlled substance prescriptions — including Schedule II stimulants — must be transmitted electronically in West Virginia. Your Aetna ADHD provider must be EPCS-registered and certified. Non-stimulant medications (atomoxetine, guanfacine ER, clonidine ER, viloxazine) are not controlled substances and are not subject to this requirement.

What if Aetna denies my ADHD medication prior authorization?

If Aetna or CVS/Caremark denies a prior authorization for your ADHD medication, you have the right to file an internal appeal. Aetna must review the appeal within 30–60 days (or within 72 hours for expedited appeals with documented urgency). If the internal appeal is denied, you may request an Independent Medical Review through the West Virginia Insurance Commissioner’s office at 1-888-879-9842. West Virginia SB 267 requires PA requests to be submitted electronically via Availity.

Does West Virginia parity law require Aetna to cover ADHD treatment equally?

Yes, for fully insured Aetna plans. W. Va. Code § 33-25-8r et seq. requires that behavioral health benefits — including ADHD — be covered at parity with medical and surgical benefits. Aetna may not impose more restrictive visit limits, copays, or prior authorization requirements for ADHD treatment than for comparable medical conditions. Self-funded employer plans are governed by federal MHPAEA rather than the state statute.

Disclaimer: Coverage details, formulary tiers, and prior authorization requirements vary by Aetna plan type, employer group, and enrollment year. This article is for informational purposes only and does not constitute insurance or legal advice. Always verify your specific benefits directly with Aetna (1-800-872-3862) and CVS/Caremark (1-800-552-8159) before beginning treatment. Coverage is not guaranteed.